Blackstone finalizes R&D pact with Alnylam as part of earlier $2 billion investment

Back in April, Blackstone announced a massive, multibillion dollar investment in Alnylam Pharmaceuticals, but not all the R&D details were finalized. On Monday, we got a glimpse at how some of those details ended up looking.